Chinese state-owned pharmaceutical company Sinopharm said on Wednesday that data for its Covid-19 vaccine is performing “better than expected” after it conducted large clinical trials.
Two of the manufacturer’s vaccine candidates have entered phase three clinical trials, during which the safety of a new drug is tested on a large group of people.
Continue reading https://on.rt.com/auqt